Oncoscience | Publication shows benefit in patients with locally advanced or metastatic pancreatic cancer treated with nimotuzumab in combination with gemcitabine.

Publication shows benefit in patients with locally advanced or metastatic pancreatic cancer treated with nimotuzumab in combination with gemcitabine.

Oncoscience | November 17th, 2017

New publication shows benefit in patients with locally advanced or metastatic pancreatic cancer treated with nimotuzumab...
legal form changed

Oncoscience | August 22nd, 2017

We are now Oncoscience GmbH. Managing directors are Dr. Dirk Reuter, Dr. Budhi Simon and Robert Ellerson....